Bill Would Allow Medicaid to Pay for Cervical/Breast Cancer Treatment

Publication
Article
OncologyONCOLOGY Vol 13 No 5
Volume 13
Issue 5

States would be allowed the option to provide Medicaid coverage for women with breast and cervical cancer through the

States would be allowed the option to provide Medicaid coverage for women with breast and cervical cancer through the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), if a new bill (S. 662/H.R. 1070) becomes law. The bill has bipartisan support in both the House and Senate.

Run by the Centers for Disease Control and Prevention, the NBCCEDP brings critical breast and cervical cancer screening and follow-up services and information to women at highest risk for these cancers—older women, the poor, the uninsured and underinsured, and racial and ethnic minorities. The program is restricted by federal law, from using federal funding for treatment services. To that end, states have developed various treatment systems that blend together a wide range of strategies, including use of public hospitals, access to county indigent care funds and hospital community-benefit programs, and individually negotiated payment plans. But funding for these treatment approaches is ever more doubtful.

The Senate version of the proposed bill gives a state the option of including a woman who tests positive for either of those two cancers in its Medicaid program, but only for the duration of the cancer treatment. Pam Dougherty, manager of federal government relations for the American Cancer Society (ACS), thinks that Congress may well pass this bill. However, she recognizes that the debate on funding treatment services will shift over to the state legislatures, since the federal proposal (S. 662) grants states only an option to pick up these services. The next challenge will be to convince the states that this option is critical for the continuation of a very important program.

Since the NBCCEDP program was established in 1991, there have been 1.7 million breast cancer and 951,000 cervical cancer screenings, serving over 1.2 million women who do not routinely seek health services. Dougherty says that the program is reaching only about 15% of eligible women. The NBCCEDP program is funded at $159 million for the current 1999 fiscal year. The Clinton administration has proposed the same figure for fiscal 2000. The ACS wants the budget increased to $215 million.

Recent Videos
Updated results from the 1b/2 ELEVATE study elucidate synergizing effects observed with elacestrant plus targeted therapies in ER+/HER2– breast cancer.
Patients with ESR1+, ER+/HER2– breast cancer resistant to chemotherapy may benefit from combination therapy with elacestrant.
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Related Content